Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Up 30.1% in February

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) was the target of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 95 shares, a growth of 30.1% from the January 29th total of 73 shares. Based on an average daily volume of 7,082 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 7,082 shares, the short-interest ratio is presently 0.0 days.

Bitwise MARA Option Income Strategy ETF Trading Up 0.9%

IMRA stock traded up $0.14 during trading on Monday, reaching $14.89. 3,738 shares of the stock were exchanged, compared to its average volume of 6,408. The stock has a 50 day simple moving average of $15.32 and a 200-day simple moving average of $25.49. Bitwise MARA Option Income Strategy ETF has a twelve month low of $11.99 and a twelve month high of $60.73. The company has a market capitalization of $3.57 million, a P/E ratio of 297.80 and a beta of -6.67.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.